Cost-effectiveness of recombinant versus urinary follicle stimulating hormone; whose point of view?

  • B Ola
  • , M Afnan
  • , K Sharif
  • , N Hammadieh
  • , S Papaioannou
  • , A Coomarasamy

Research output: Contribution to journalArticlepeer-review

4 Citations (Scopus)
Original languageEnglish
Pages (from-to)1141-2
Number of pages2
JournalActa obstetricia et gynecologica Scandinavica
Volume80
Issue number12
Publication statusPublished - Dec 2001

Keywords

  • Adult
  • Cost-Benefit Analysis
  • Drug Costs
  • Female
  • Fertilization in Vitro
  • Follicle Stimulating Hormone
  • Humans
  • Recombinant Proteins

Cite this